glp 1 inhibitor mechanism What is GLP-1 and Its Receptor Agonists? Mechanism of action for GLP-1R
Description
Sarah Welsh, Co-Founder and Chief Product Officer of HANX
Because it is not FDA-approved, it cannot be legally manufactured, marketed, sold, or prescribed in the United States outside of a registered clinical trial
GLP-1s, more formally called GLP-1 receptor agonists , are a relatively new and emerging class of medications used to treat diabetes and/or obesity
Both are delivered via weekly injections
Preclinical data indicated that tirzepatide exhibited an affinity for GIPR equivalent to GIP binding, while its affinity for GLP-1R was approximately five times weaker compared to GLP-1 (63)
